OKYO Pharma logo

OKYO - OKYO Pharma News Story

14.65p -2.1  -12.5%

Last Trade - 11/08/20

Sector
Healthcare
Size
Small Cap
Market Cap £93.9m
Enterprise Value £93.8m
Revenue £n/a
Position in Universe 954th / 1819

BRIEF-Okyo Pharma Announces Potent Anti-Inflammatory Effects Of OK-113 In Mouse Model Of Dry Eye Disease

Wed 28th August, 2019 7:31am
Aug 28 (Reuters) - OKYO Pharma Ltd  OKYO.L :
    * CHEMERIN UPDATE
    * ANNOUNCES POTENT ANTI-INFLAMMATORY EFFECTS OF OK-113 IN A
MOUSE
MODEL OF DRY EYE DISEASE

Source text for Eikon:  ID:nRSb3319Ka 
Further company coverage:  OKYO.L 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.